Weekly reads: NurOwn, key gene screen, MS, Croce mess
I get a lot of questions about stem cells for ALS and more recently people have been specifically interested in NurOwn from BrainStorm Cell Therapeutics. Recently, the FDA denied BrainStorm’s request for a BLA for NurOwn. The company felt its Phase III trial was encouraging. It sounds like they will move forward with a follow-up […]
Weekly reads: NurOwn, key gene screen, MS, Croce mess Read More »